Ignite Creation Date:
2025-12-24 @ 2:47 PM
Ignite Modification Date:
2026-02-21 @ 3:50 PM
Study NCT ID:
NCT02513459
Status:
COMPLETED
Last Update Posted:
2020-04-24
First Post:
2015-07-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Long Term Extension Trial of BI 655066/ABBV-066 (Risankizumab), in Patients With Moderately to Severely Active Crohn's Disease
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-09-16
Start Date Type:
ACTUAL
Primary Completion Date:
2019-06-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-06-19
Completion Date Type:
ACTUAL
First Submit Date:
2015-07-30
First Submit QC Date:
None
Study First Post Date:
2015-07-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-04-09
Results First Submit QC Date:
None
Results First Post Date:
2020-04-24
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-04-09
Last Update Post Date:
2020-04-24
Last Update Post Date Type:
ACTUAL